National Health Investors, Inc. $NHI Shares Bought by Sumitomo Mitsui Trust Group Inc.

Key Points

• Sumitomo Mitsui Trust Group increased its NHI stake by 374.8% in the third quarter, adding 189,096 shares to hold 239,542 shares valued at about $15.7 million.
• Institutional investors own 62.51% of National Health Investors. The REIT reported quarterly EPS of $1.19 and revenue of $121.32 million, up 1.6% year over year, and guided to full-year EPS of $4.74–$4.79.
• Analysts’ consensus rating is “Moderate Buy,” with an average price target of $81; shares opened at $71.50.

Sumitomo Mitsui Trust Group Inc. boosted its position in National Health Investors, Inc. (NYSE:NHI - Free Report) by 374.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 239,542 shares of the real estate investment trust's stock after purchasing an additional 189,096 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.49% of National Health Investors worth $15,721,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in NHI. EverSource Wealth Advisors LLC lifted its stake in shares of National Health Investors by 34.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust's stock worth $51,000 after acquiring an additional 160 shares during the last quarter. Assetmark Inc. grew its position in National Health Investors by 13.5% in the 1st quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust's stock valued at $110,000 after acquiring an additional 161 shares during the last quarter. GAMMA Investing LLC grew its position in National Health Investors by 38.0% in the 3rd quarter. GAMMA Investing LLC now owns 603 shares of the real estate investment trust's stock valued at $40,000 after acquiring an additional 166 shares during the last quarter. Versant Capital Management Inc increased its stake in National Health Investors by 108.5% in the third quarter. Versant Capital Management Inc now owns 415 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 216 shares during the period. Finally, Wealthspire Retirement LLC increased its stake in National Health Investors by 0.9% in the first quarter. Wealthspire Retirement LLC now owns 25,318 shares of the real estate investment trust's stock worth $2,047,000 after purchasing an additional 221 shares during the period. Institutional investors own 62.51% of the company's stock.

National Health Investors Stock Up 0.3%

Shares of NYSE:NHI opened at $71.50 on Friday. National Health Investors, Inc. has a 52-week low of $63.51 and a 52-week high of $91.38. The stock has a market cap of $3.51 billion, a P/E ratio of 20.67, a price-to-earnings-growth ratio of 4.54 and a beta of 0.51. The business's 50 day moving average is $67.84 and its 200 day moving average is $76.23. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%. The company had revenue of $121.32 million for the quarter. During the same quarter in the previous year, the business earned $1.22 earnings per share. The company's revenue for the quarter was up 1.6% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Sell-side analysts predict that National Health Investors, Inc. will post 4.76 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. BMO Capital Markets reiterated an "outperform" rating on shares of National Health Investors in a research report on Wednesday, September 23rd. Truist Financial cut their price target on shares of National Health Investors from $81.00 to $80.00 and set a "buy" rating on the stock in a report on Wednesday, September 2nd. Zacks Research raised shares of National Health Investors from a "strong sell" rating to a "hold" rating in a research note on Tuesday, September 29th. National Bank Financial set a $79.00 price target on shares of National Health Investors in a research note on Wednesday, September 9th. Finally, Wells Fargo & Company decreased their price objective on shares of National Health Investors from $78.00 to $68.00 and set an "equal weight" rating for the company in a report on Monday, October 19th. Five research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, National Health Investors has a consensus rating of "Moderate Buy" and a consensus target price of $81.00.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a real estate investment trust that owns and finances income-producing healthcare real estate in the United States. The company primarily focuses on properties serving older adults and patients who require specialized care.

NHI's portfolio includes independent living communities, assisted living and memory care facilities, skilled nursing facilities, continuing care retirement communities, medical office buildings and other healthcare-related properties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.